Extracellular volume (ECV) fraction might represent a useful parameter for the noninvasive quantification of pancreatic fibrosis, and the proton density fat fraction (FF) of pancreas can be obtained by mDxion Quant. Here, we hypothesized that pancreatic ECV and FF, for evaluation of pancreatic fibrosis and fat content, can be used to assess patients with liver cirrhosis. Results indicated that pancreatic ECV at 60 mins after contrast agent administration showed a statistical difference between liver cirrhosis patients and controls. A significant correlation was observed between pancreatic FF and ECV at 5 mins after administration.
This abstract and the presentation materials are available to members only; a login is required.